Latest Health Care News

Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.

Ramsay Health Care is set to simplify its corporate structure by distributing its majority stake in European healthcare provider Ramsay Santé directly to shareholders, enabling focused growth strategies for both entities.

Emyria has secured expanded funding from Medibank to support its Treatment-Resistant Depression and PTSD programs at a new clinic in Victoria, marking a significant step in its national mental health care rollout.

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.

Ramsay Health Care has cleared a major regulatory hurdle with ACCC approval to acquire National Capital Private Hospital, setting the stage for completion in early fiscal 2027.

Nutritional Growth Solutions reports improved cash flow and cost savings amid leadership changes, setting the stage for renewed growth in FY26.

TrivarX Limited has reported compelling clinical trial results demonstrating its single-lead ECG algorithm’s high sensitivity in detecting major depressive episodes among US veterans, marking a significant step in objective mental health screening.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Anagenics Limited has announced a two-tranche placement to raise A$2.25 million, aiming to expand its health and wellness brands while retiring debt and supporting working capital.

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.

Nutritional Growth Solutions (ASX – NGS) has locked in a $2 million capital raise through a share placement aimed at fueling sales, inventory, and growth initiatives, pending shareholder approval.

Nutritional Growth Solutions reported a 13% revenue increase in Q3 FY25, driven by expanded US retail distribution and inventory replenishment. The company raised AU$760k to support growth but faces a tight cash runway, banking on upcoming capital raises and retail momentum.